Robbert Q Kim

14PUBLICATIONS

66CO-AUTHORS

Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Wastewater treatment processesMajor global burdens of diseasePharmaceutical delivery technologies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 19, 2026

USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I production.

|Apr 06, 2026

Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma.

Ziyun Cheng, Mohamadreza Amin, Mandy van Brakel

|Feb 04, 2026

Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxA.

Arina Koroleva, Erika Artukka, Keith Yamada

|Sep 17, 2024

Covalent Probes To Capture <i>Legionella pneumophila</i> Dup Effector Enzymes.

Max S Kloet, Rishov Mukhopadhyay, Rukmini Mukherjee

|May 07, 2024

Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell.

Yuqing Jia, Merve Oyken, Robbert Q Kim

|Aug 29, 2023

Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2.

Jin Gan, Jelle de Vries, Jimmy J L L Akkermans

Pageof 3

Frequent Collaborators

Aysegul Sapmaz

Paul P Geurink

Peter A van Veelen

Huib Ovaa

Elma Mons

Monique P C Mulder

Gerbrand J van der Heden van Noort

2 joint publications

Jacques Neefjes

2 joint publications

Yuqing Jia

1 joint publications

Bjorn R van Doodewaerd

Frequent Collaborators

Aysegul Sapmaz

Paul P Geurink

Peter A van Veelen

Huib Ovaa